Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

doi 10.2174/978160805132811001010019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BENTHAM SCIENCE PUBLISHERS

Related search

Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2009English

Hypofractionated Stereotactic Re-Irradiation: Treatment Option in Recurrent Malignant Glioma

BMC Cancer
Cancer ResearchOncologyGenetics
2005English

Salvage Fractionated Stereotactic Re-Irradiation (FSRT) for Patients With Recurrent High Grade Gliomas Progressed After Bevacizumab Treatment

JHN Journal
2018English

Recurrent Malignant Gliomas

Seminars in Radiation Oncology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2014English

Stereotactic Hypofractionated Irradiation for Metastatic, Inoperable, and Recurrent Malignancies: A Modern Necessity, Rather Than a Luxury

Journal of Radiotherapy
2014English

Radiosurgery and Hypofractionated Stereotactic Irradiation With Photons or Protons for Tumours of the Skull Base

2013English

Clinical Outcomes of Proton Beam Re-Irradiation for Recurrent Gliomas

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Stereotactic Radiosurgery for Gliomas

2011English

Efficacy of Bevacizumab Therapy in Recurrent Malignant Gliomas in Relation to the Prior Recurrence Pattern or Tumor Location

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy